Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.

MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio today announced Precision-T, its pivotal Phase 3 study, is open, enrolling and treating patients at clinical trial sites.

Click to view original post